Edition:
United Kingdom

Capricor Therapeutics Inc (CAPR.OQ)

CAPR.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
8:59pm GMT
Change (% chg)

$0.04 (+2.26%)
Prev Close
$1.77
Open
$1.76
Day's High
$1.92
Day's Low
$1.76
Volume
106,451
Avg. Vol
127,318
52-wk High
$4.25
52-wk Low
$0.63

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.31 -0.117
Jun '17 1.00 -0.157
Mar '17 0.88 -0.171
FY 2016 Dec '16 0.91 -0.211
Sep '16 0.75 -0.292
Jun '16 1.13 -0.261
Mar '16 1.22 -0.258
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 1 2.90 2.90 2.90 0.00
Earnings (per share)
Year Ending Dec-18 1 -0.54 -0.54 -0.54 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -2.65 0.90 0.89
Price to Sales (TTM) 19.03 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) -- 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 3.23 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.80 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -26.18 78.63 5.59
Sales - 5 Yr. Growth Rate 24.17 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.94 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 8.12 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 149.85 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 0.82 5.30 2.97
LT Debt to Equity (MRQ) -- 22.82 12.22
Total Debt to Equity (MRQ) -- 24.47 16.52
Interest Coverage (TTM) -58.74 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -423.45 -- --
EBITD - 5 Yr. Avg -265.04 -572.68 10.86
Operating Margin (TTM) -470.06 -717.10 4.64
Operating Margin - 5 Yr. Avg. -287.51 -594.00 6.26
Pre-Tax Margin (TTM) -481.18 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -292.39 -597.35 6.60
Net Profit Margin (TTM) -481.18 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -292.39 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,602,121 855,668,157
Net Income/Employee (TTM) -- 2,968,747 100,655,595
Receivable Turnover (TTM) 13.29 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.25 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -120.88 -1.05 10.98
Return on Assets - 5 Yr. Avg. -96.30 -0.57 12.37
Return on Investment (TTM) -645.84 1.66 14.43
Return on Investment - 5 Yr. Avg. -149.85 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -- 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -27.53 99.55 24.17
EPS (TTM) % -25.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Capricor Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 177.67 168.10 99 53
13 Week 326.87 306.08 99 62
26 Week -0.69 -8.24 99 77
52 Week -15.13 -28.07 75 50
YTD 7.52 -5.58 98 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.46%
# of Holders: 25
Total Shares Held: 2,431,029
3 Mo. Net Change: 1,437,262
# New Positions: 7
# Closed Positions: 4
# Increased Positions: 13
# Reduced Positions: 5
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.